RETRACTED: Outcome of neurocritical disorders, a multicenter prospective cross‐sectional study

Abstract

Background: Patients with neurocritical disorders who require admission to intensive care units (ICUs) constitute about 10-15% of critical care cases. Objectives:To study the outcome of neurocritical disorders in intensive care units.Methodology: This is a prospective cross-sectional study that was conducted among neurocritical patients who were admitted in four intensive care units of four major hospitals in Khartoum state during the period from November 2020 to March 2021.Results: Seventy-two neurocritical patients were included in this study; 40(55.6%) were males and 32(44.4%) were females. Twenty-one (29.2%) patients fully recovered, 35 (48.6%) partially recovered and 16 (22.2%) died. The mortality of the common neurocritical diseases were as follows: stroke 30.4%, encephalitis (8.3%), status epilepticus (11.1%), Guillain-Barre syndrome (GBS) (16.7%), and myasthenia gravis (MG) (25%). Conclusion:This study identified that near two-thirds of the patients required mechanical ventilation. Delayed admission was observed due to causes distributed between the medical side and patient side. The majority of patients were discharged from ICU with partial recovery.

Complicaciones neurológicas como motivo de ingreso en una Unidad de Cuidados Intensivos Oncológicos

“…En poblaciones neurocríticas no traumáticas y sin cáncer, los motivos de ingreso principales en UCI son similares a los neurooncológicos [26], [27].…”

Approach to acute encephalitis in the intensive care unit

“…Encephalitis is a neurological emergency caused by inflammation of the brain parenchyma and associated with a wide array of etiologies subdivided into two major groups: infectious encephalitis (IE) and autoimmune encephalitis (AE) [1]. Earlier epidemiological studies identified infectious pathogens as the main culprits behind encephalitis, whereas more recently, there has been a dramatic increase in the identification of AE associated with neuronal autoantibodies [2].…”

Personality factors in patients with myasthenia gravis: A prospective study

“…The disease is caused by an immunological impairment in neuromuscular transmission. The course of MG may be unstable, especially in the early stages of the disease and include the risk of crisis (Abuzinadah et al., 2020 ; Ali et al., 2022 ). It is well known that anxiety disorders and depression are considered common comorbidities in patients with MG and correlate with disease severity (Bogdan et al., 2020b ; Nadali et al., 2022 ; Suzuki et al., 2011 ).…”